Avoiding scale-up pitfalls: upstream process development strategies for AAV manufacturing
February 26th, 2025
Cell & Gene Therapy Insights
Watch the on-demand webinar about how upstream process developers like you can scale your AAV manufacturing from shake flasks to 200L bioreactors and beyond.
This live event will be featured in greater detail shortly, but in the mean time, access the data, expertise, and case studies at the link above to start scaling your AAV yield today. See what techniques and solutions transfection experts Hugh Murray (MilliporeSigma) and Sandy Tseng (Mirus Bio) recommend to maintain high titer, and percent full capsids while scaling up.
Watch other archived events here, or watch more in the AAV scale-up series.
Transfection Innovation Webinar: Building of TransIT®-AAViator
A Novel Transfection System: the newest transfection system and case study
Bioprocess Optimization: How to Save Millions Over the Life of Your Drug Asset